Kalaris Therapeutics Inc (KLRS) vs Pliant Therapeutics, Inc. (PLRX)
A side-by-side comparison of Kalaris Therapeutics Inc and Pliant Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KLRS
Kalaris Therapeutics Inc
$2.66HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PLRX
Pliant Therapeutics, Inc.
$1.03HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — KLRS vs PLRX
growth of $100 · dividends reinvested · last 6yKLRS -99.1% (-54.0%/yr)PLRX -95.2% (-39.6%/yr)PLRX compounded faster over this window
Log scale — wide-divergence pair
KLRS PLRX
KLRS vs PLRX: by the numbers
- •PLRX is the larger company ($64M vs $58M market cap).
Metrics side by side
Valuation
| Metric | KLRS | PLRX |
|---|---|---|
| P/B ratio | 1.01 | 0.43 |
Profitability
| Metric | KLRS | PLRX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -76.75% | -62.81% |
| ROIC | -52.40% | -56.22% |
Growth (annualized)
| Metric | KLRS | PLRX |
|---|---|---|
| Total return CAGR (5Y) | -81.13% | -43.17% |
Frequently asked
- How have KLRS and PLRX total returns compared?
- Over the past 5 years, KLRS delivered -81.13% and PLRX delivered -43.17% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.